Search results
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 2 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 4 hours agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 1 day agoIn the past six months, shares of MRNA have rallied 108.94%. (See the last biotech stock roundup...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 4 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 4 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.51% By Investing.com
Investing.com· 2 days agoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.51%
Arcturus Therapeutics’ (ARCT) Outperform Rating Reaffirmed at William Blair
ETF DAILY NEWS· 14 hours agoARCT has been the topic of a number of other research reports. Canaccord Genuity Group lowered their target price on shares of Arcturus Therapeutics from $87.00 to $86.00 and set a buy rating ...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoAll this pulled up the stock price. The acquisition of Harpoon Therapeutics added its lead pipeline...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoThe stock, however, keeps going up. Moderna shares have climbed 20% just this week, and 45% since...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks via Yahoo Finance· 1 day agoImage Source: Zacks Investment Research Descartes-08 is an autologous anti-B cell maturation antigen...